Cross-Border Regulatory Watch

The Singapore Food Agency (SFA) and Hong Kong Centre for Food Safety (CFS) issued product recall advisories in April 2024 for specific export lots containing ethylene oxide residues exceeding maximum residue limits (MRL). The European Union prohibits ethylene oxide in foodstuffs under Regulation (EC) 396/2005.

Potassium bromate was traditionally utilized as a flour maturing agent to strengthen gluten elasticity. The European Union prohibited it under Directive 90/496/EEC, followed by the UK, Canada, and China. FSSAI formally prohibited potassium bromate in all food products in India in June 2016.

The US FDA issued Import Alerts 33-15 and 33-16 establishing automatic detention on mini-cup jelly confections containing konjac. The European Commission prohibited placing mini-cup jellies containing konjac on the market under Decision 2002/271/EC following documented pediatric asphyxiation fatalities.

The US FDA issued an official Safety Alert in August 2018 warning consumers against eating or handling foods prepared with liquid nitrogen at the point of sale. Indian state food safety authorities (e.g. Tamil Nadu and Karnataka in 2024) prohibited serving liquid nitrogen directly in ready-to-eat foods under FSSAI Section 34.

Nimesulide was never approved by the US FDA due to liver toxicity concerns. The European Medicines Agency (EMA) concluded safety assessments in 2012 restricting oral therapy to acute pain for a maximum duration of 15 days. India's CDSCO prohibited nimesulide formulations in pediatric patients under 12 years of age in February 2011 (Gazette Notification GSR 82(E)).

The US FDA withdrew metamizole marketing authorization in 1977 due to the risk of agranulocytosis. It was similarly withdrawn in the UK, Australia, and Sweden. In India, CDSCO suspended Analgin in June 2013 (GSR 378(E)), but revoked the suspension in February 2014, placing it under Schedule H1 with mandatory box warnings.

Sibutramine was withdrawn globally (US FDA, EMA, Health Canada) in 2010 following results from the SCOUT clinical trial, which confirmed a 16% increase in major adverse cardiovascular events (MACE). India's CDSCO formally prohibited sibutramine manufacturing, sale, and distribution in November 2010 (GSR 911(E)).

Cisapride was withdrawn in the US in 2000 and the EU in 2002 after post-marketing surveillance documented over 300 instances of ventricular arrhythmias and Torsades de Pointes. India's CDSCO statutorily prohibited cisapride manufacture, sale, and distribution in February 2011 (GSR 81(E)).

Dextropropoxyphene was withdrawn from the European market in 2009 (EMA recommendation) and the US in November 2010 following FDA clinical safety data demonstrating cardiotoxicity at therapeutic dosages. India's CDSCO prohibited dextropropoxyphene formulations in May 2013 (GSR 320(E)).

The US FDA issued an urgent Safety Communication warning that high levels of biotin in patient blood severely interfere with hospital laboratory tests. Many blood tests (including cardiac Troponin, which detects active heart attacks, and thyroid TSH tests) rely on biotin-streptavidin technology. High biotin can falsely show normal troponin during a real heart attack, leading to missed diagnoses and death.

The US FDA and global regulatory bodies issued multiple warnings stating colloidal silver is neither safe nor effective for treating any disease. Silver has zero known essential function in the human body. Chronic intake causes silver particles to deposit permanently in internal organs and skin, turning the patient's skin irreversibly blue-gray (argyria), and causing kidney damage and neurological toxicity.

The US FDA, DEA, and multiple European health agencies warn consumers against using Mitragyna speciosa (kratom). Its active alkaloids bind directly to the same brain receptors as morphine, carrying severe risks of physical addiction, opioid-like withdrawal, respiratory depression, seizures, and acute drug-induced liver injury.

The US FDA issued urgent nationwide warnings against convenience-store supplements containing tianeptine. Although prescribed in tiny doses in a few countries, grey-market capsules contain massive, unstandardized doses that act like a hard opioid, causing rapid addiction, coma, dangerously slow breathing, and fatal overdoses.

Global health authorities (WHO, FDA, EMA, AYUSH) strictly ban Aristolochia plant species after thousands of patients suffered permanent kidney failure ('aristolochic acid nephropathy') and upper urinary tract cancers from contaminated herbal weight-loss and joint formulas.

The WHO, US FDA, and state drug controllers repeatedly seize imported skin-lightening creams containing up to 10,000–30,000 ppm of toxic mercury—thousands of times above the 1 ppm legal trace limit.

FDA laboratory testing consistently finds over 80% of gas-station 'all-natural herbal' male enhancement supplements contain unlisted, dangerous doses of sildenafil (the active drug in Viagra) or untested chemical mimics. When taken by anyone using heart medicines like nitroglycerin, this causes a fatal drop in blood pressure.

Health Canada and the US FDA have issued recurring public import alerts (FDA Import Alert 54-16) regarding uncertified traditional herbal preparations containing lead, mercury, or arsenic levels exceeding acceptable daily intake thresholds.

Mustard seed oil naturally contains 30% to 50% erucic acid. The US FDA prohibits mustard oil containing erucic acid from being marketed for human culinary consumption (21 CFR 172.859), requiring imported containers to bear 'For External Use Only' labels. The European Union limits erucic acid to 20 g/kg (2%) in vegetable oils under Regulation (EU) 2019/1602.

Municipal public health authorities periodically issue temporary suspensions on street-vended snacks during seasonal monsoon cholera outbreaks due to non-potable water supplies (e.g., Kathmandu Metropolitan City order, 2022).

The European Union authorizes silver (E174) with strict purity specifications, while the US FDA regulates silver under 21 CFR 73.2500 with defined limitations. In India, FSSAI established mandatory standards requiring a minimum 99.9% silver purity and prohibiting animal-origin processing methods in 2016.

Monotonous dietary reliance on Lathyrus sativus (>30% of caloric intake for over 2 months) causes neurolathyrism. India instituted a statutory ban under the Prevention of Food Adulteration Act in 1961. In 2016, FSSAI authorized agricultural cultivars scientifically bred for low ODAP content (<0.1%).

This fixed-dose combination was never authorized by the US FDA or UK MHRA, and was discontinued in Denmark. CDSCO issued a suspension in India in July 2013 (GSR 475(E)), which was subsequently stayed and reassessed following manufacturer litigation and Parliamentary Standing Committee inquiries.

Human placental extract preparations are approved and marketed in India under CDSCO biologics oversight for chronic wound healing and pelvic inflammatory conditions. The US FDA and EMA have not authorized human placental extracts for topical or systemic wound healing, citing donor tissue standardization and biological pathogen safety parameters.

Independent investigative analyses of commercial dietary supplements (including studies published in Clinical and Experimental Hepatology in 2024 and Clean Label Project assessments in the US) documented heavy metal residues in uncertified protein formulations. FSSAI issues recurring compliance notices for non-compliant nutraceutical claims.

The US CDC and JAMA published warnings in 2023 following a 530% surge in pediatric hospital visits from candy-like melatonin gummies. Independent laboratory testing revealed that 88% of tested commercial gummy brands were inaccurately labeled, containing between 74% and 347% of the stated amount, with some even containing unlisted CBD.

While melatonin is a prescription-only medicine in the UK, EU, Australia, and Japan, it is sold loosely as a dietary supplement in the US and online. Landmark JAMA laboratory testing of 25 commercial melatonin gummies found actual melatonin levels ranged from 74% to 347% of the printed label, with several products secretly containing unlisted serotonin or cannabidiol (CBD).

Long banned in Europe, Japan, and India, the US FDA officially revoked the food-additive authorization for Brominated Vegetable Oil (BVO) in July 2024 after NIH toxicology studies proved it causes thyroid damage and builds up in body fat.

European health authorities (France, Austria, Sweden, Czechia) and multiple US state regulators have issued statutory bans against HHC and unregulated semi-synthetic cannabinoid vapes due to toxic heavy-metal catalyst residues and acute psychiatric emergency room visits.

In October 2024, India's Central Consumer Protection Authority (CCPA) penalized Britannia Industries ₹1 Lakh for misleading everyday consumers. Britannia marketed packaged bread under a giant front label reading '100% Whole Wheat Bread'. However, official ingredient checks revealed the bread actually contained only about 62% whole wheat flour (atta) blended with 38% refined white flour (maida). The CCPA ruled this an illegal unfair trade practice and ordered Britannia to immediately stop using the '100%' claim.

Under European Parliament Regulation (EC) 1333/2008, foodstuffs containing six synthetic azo colorants must bear the statutory warning: 'May have an adverse effect on activity and attention in children.' In India, FSSAI permits these colorants up to a statutory maximum limit of 100 mg/kg without behavioral warning statements.

While poppy seeds do not produce significant opioids internally, harvest processing can transfer plant latex containing morphine and codeine to seed surfaces. Jurisdictions including Singapore (CNB), UAE, and Saudi Arabia classify poppy seeds as controlled substances. The European Union established maximum morphine equivalent levels in 2022 (Regulation EU 2021/2143).

Fixed-dose combinations of domperidone with PPIs are widely prescribed in India for GERD and dyspepsia. In Europe, the EMA restricted domperidone to nausea and vomiting alone at a maximum dose of 30 mg/day for up to 7 days, warning against use in patients with cardiac conduction issues. Domperidone is not approved by the US FDA.

Health authorities in Denmark (DTU Food), the Netherlands, and France (ANSES) published safety evaluations after medical hepatology registries documented cases of acute cholestatic jaundice and herb-induced liver injury (HILI) in individuals taking high-dose alcohol-extracted ashwagandha supplements.